Windward gets bispecific from Qyuns in its second China deal of the year
Windward Bio今年在华的第二笔交易：从Qyuns Therapeutics获得双特异性药物

Swiss biotech Windward Bio is picking up a second drug candidate from a China biotech this year, seeking to bring multiple medicines to market for respiratory and dermatology conditions.
瑞士生物技术公司 Windward Bio（暂未有公开中文正式名称）今年将从一家manbetx3.0 生物医药企业引进第二个药物候选物，旨在为呼吸系统与皮肤病领域将多款药物推向市场。